Healthcare provider profile · identity verified

David John Moran, MD

Family Practice · FORT WAYNE, IN · NPI 1679688295

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	266	77
Amlodipine Besylate	Amlodipine Besylate	232	72
Atorvastatin Calcium	Atorvastatin Calcium	181	65
Lisinopril	Lisinopril	173	60
Hydrochlorothiazide	Hydrochlorothiazide	155	46
Losartan Potassium	Losartan Potassium	136	40
Omeprazole	Omeprazole	136	44
Rosuvastatin Calcium	Rosuvastatin Calcium	123	42
Metformin Hcl	Metformin Hcl	105	35
Pantoprazole Sodium	Pantoprazole Sodium	100	35
Metoprolol Succinate	Metoprolol Succinate	82	24
Bupropion Xl	Bupropion Hcl	81	21
Escitalopram Oxalate	Escitalopram Oxalate	81	25
Simvastatin	Simvastatin	79	26
Tamsulosin Hcl	Tamsulosin Hcl	75	27
Valsartan	Valsartan	71	23
Meloxicam	Meloxicam	69	28
Fluoxetine Hcl	Fluoxetine Hcl	68	22
Ezetimibe	Ezetimibe	64	21
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	64	21
Glipizide Er	Glipizide	62	15
Pravastatin Sodium	Pravastatin Sodium	54	16
Jardiance	Empagliflozin	49	suppressed
Prednisone	Prednisone	48	38
Ozempic	Semaglutide	47	11
Irbesartan	Irbesartan	44	13
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	41	15
Lovastatin	Lovastatin	40	11
Atenolol	Atenolol	39	11
Famotidine	Famotidine	38	13
Mounjaro	Tirzepatide	38	suppressed
Duloxetine Hcl	Duloxetine Hcl	36	suppressed
Carvedilol	Carvedilol	35	13
Metformin Hcl Er	Metformin Hcl	35	13
Gabapentin	Gabapentin	33	15
Benazepril Hcl	Benazepril Hcl	32	suppressed
Allopurinol	Allopurinol	31	suppressed
Montelukast Sodium	Montelukast Sodium	30	13
Citalopram Hbr	Citalopram Hydrobromide	28	suppressed
Trazodone Hcl	Trazodone Hcl	27	14
Trulicity	Dulaglutide	27	suppressed
Potassium Chloride	Potassium Chloride	26	suppressed
Sertraline Hcl	Sertraline Hcl	26	suppressed
Mirtazapine	Mirtazapine	25	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	24	suppressed
Eliquis	Apixaban	24	suppressed
Alendronate Sodium	Alendronate Sodium	23	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	22	suppressed
Furosemide	Furosemide	21	suppressed
Januvia	Sitagliptin Phosphate	21	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	21	suppressed
Fluticasone Propionate	Fluticasone Propionate	20	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	20	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	20	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	20	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	19	suppressed
Buspirone Hcl	Buspirone Hcl	19	12
Celecoxib	Celecoxib	19	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	19	suppressed
Glipizide	Glipizide	18	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	18	suppressed
Raloxifene Hcl	Raloxifene Hcl	16	suppressed
Spironolactone	Spironolactone	16	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	16	14
Amoxicillin	Amoxicillin	15	14
Cefdinir	Cefdinir	14	11
Clopidogrel	Clopidogrel Bisulfate	14	suppressed
Synthroid	Levothyroxine Sodium	14	suppressed
Cephalexin	Cephalexin	13	13
Nebivolol Hcl	Nebivolol Hcl	13	suppressed
Tresiba Flextouch U-100	Insulin Degludec	13	suppressed
Valacyclovir	Valacyclovir Hcl	13	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	13	suppressed
Breo Ellipta	Fluticasone/Vilanterol	12	suppressed
Farxiga	Dapagliflozin Propanediol	12	suppressed
Humulin R U-500 Kwikpen	Insulin Regular, Human	12	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	12	suppressed
Memantine Hcl	Memantine Hcl	12	suppressed
Ropinirole Hcl	Ropinirole Hcl	12	suppressed
Diltiazem Hcl	Diltiazem Hcl	11	suppressed
Glipizide-Metformin	Glipizide/Metformin Hcl	11	suppressed
Levetiracetam	Levetiracetam	11	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	11	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error